Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Patrocinado

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Postado

73

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

Elon Musk’s ‘Five Things’ email program shut down by Trump administration: What was the controversial project that sparked panic among federal employees?

The Trump administration has ended Elon Musk's unpopular "Five Things" email program, which...

Por 0 4

Gold price falls slightly while silver inches up

KATHMANDU: The price of gold in the Nepali market dropped slightly on Wednesday, declining by Rs...

Por 0 14

NEET UG 2025 round 1 revised counselling schedule released at mcc.nic.in: Check important dates here

Por 0 17

12 arrested for stealing transformers

BIRATNAGAR: Koshi Province Police Office in Biratnagar has made public 12 individuals involved in...

Por 0 19

'Reason he can't stand up to Trump is ...': Rahul's fresh charge at PM; claims 'Modi's hands are tied'

Por 0 20